Nonulcer Dyspepsia | The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia

Nonulcer Dyspepsia research study

What is the primary objective of this study?

The aim of our study is to evaluate the effectiveness of proton pump inhibitor (PPI) treatment in patients with functional dyspepsia.

Who is eligible to participate?

Inclusion Criteria: - aged 18-45 years with symptoms of dyspepsia, - no evidence of organic disease. Exclusion Criteria: - Patients with alarm symptoms, - Severe concomitant illness, - Pregnancy or lactation, - Alcohol or drug abuse, - Use of aspirin or other non-steroidal anti-inflammatory drugs antibiotics, H2 receptor blockers, bismuth, or proton pump inhibitors in the preceding two weeks

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Nonulcer Dyspepsia

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Drug:Pantoprazol40mg/day, oral, 28 days

Drug:Folic Acid5 mg/day, oral, 28 days

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.


folic acid

Study Status

Unknown status

Start Date: June 2012

Completed Date: June 2013

Phase: Phase 4

Type: Interventional


Primary Outcome: Effectiveness of pantoprazole treatment in patients with functional dyspepsia measured by symptoms scale.

Secondary Outcome:

Study sponsors, principal investigator, and references

Principal Investigator:

Lead Sponsor: Bezmialem Vakif University


More information:

Discuss Dyspepsia